Correlation Between Medicofarma Biotech and Volkswagen

Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and Volkswagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and Volkswagen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicofarma Biotech SA and Volkswagen AG Non Vtg, you can compare the effects of market volatilities on Medicofarma Biotech and Volkswagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of Volkswagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and Volkswagen.

Diversification Opportunities for Medicofarma Biotech and Volkswagen

0.81

Correlation Coefficient

Medicofarma Biotech  Volkswagen

Very poor diversification

The 3 months correlation between Medicofarma and Volkswagen is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and Volkswagen AG Non Vtg in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Volkswagen AG Non and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with Volkswagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Volkswagen AG Non has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and Volkswagen go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and Volkswagen

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the Volkswagen. In addition to that, Medicofarma Biotech is 2.92 times more volatile than Volkswagen AG Non Vtg. It trades about -0.09 of its total potential returns per unit of risk. Volkswagen AG Non Vtg is currently generating about -0.08 per unit of volatility. If you would invest  40,310  in Volkswagen AG Non Vtg on October 5, 2024 and sell it today you would lose (3,110) from holding Volkswagen AG Non Vtg or give up 7.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.28%
Values	Daily Returns

Medicofarma Biotech SA  vs.  Volkswagen AG Non Vtg

Medicofarma Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Volkswagen AG Non

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Volkswagen AG Non Vtg has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Medicofarma Biotech and Volkswagen

The main advantage of trading using opposite Medicofarma Biotech and Volkswagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, Volkswagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Volkswagen will offset losses from the drop in Volkswagen's long position.

The idea behind Medicofarma Biotech SA and Volkswagen AG Non Vtg pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.